A sensitive quantitation method for the complement inhibitor Cp40 in human and primate plasma is developed and validated. The quantitation is based on solid-phase extraction and UPLC–ESI–MS analysis. The developed method was found to be linear, accurate and precise. The validated method was successfully applied to a pharmacokinetic profiling study of Cp40 in cynomolgus monkeys.